Publication Name	World Journal of Translational Medicine
Manuscript ID	17795
Country

Received	2015-03-25 08:53
Peer-Review Started	2015-03-26 19:23
To Make the First Decision	2015-04-27 15:30
Return for Revision	2015-04-30 16:18
Revised	2015-05-01 01:26
Second Decision	2015-06-08 11:31
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-06-16 16:56
Articles in Press	2015-06-16 16:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-07 11:09
Publish the Manuscript Online	2015-08-14 18:19

ISSN	2220-6132 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles
Manuscript Source	Invited Manuscript
All Author List	Marios Kyriazis
Funding Agency and Grant Number
Corresponding Author	Dr. Marios Kyriazis, MD, ELPIs Foundation for Indefinite Lifespans, 75 Embleton Road, London SE13 7DQ, United Kingdom. drmarios@live.it
Key Words	Rejuvenation; Biotechnologies; Translational medicine; Ageing; Clinical medicine
Core Tip	Those who rely on biomedical technologies in order to achieve rejuvenation (global reduction of age-related degeneration) are bound to be disappointed. Such a reductionist approach will not have an impact on reducing mortality as a function of age. This is due to problems and obstacles associated with human nature, which are much more complicated than hitherto recognised. The use of biomedical rejuvenation technologies in radically reducing the impact of ageing is conceptually naive, scientifically reductionist, technologically unfeasible, and medically undeliverable.
Publish Date	2015-08-14 18:19
Citation	Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles. World J Transl Med 2015; 4(2): 51-54
URL	http://www.wjgnet.com/2220-6132/full/v4/i2/51.htm
DOI	http://dx.doi.org/10.5528/wjtm.v4.i2.51

Full Article (PDF)	WJTM-4-51.pdf
Full Article (Word)	WJTM-4-51.doc
Manuscript File	17795-Review.docx
Answering Reviewers	17795-Answering reviewers.pdf
Audio Core Tip	17795-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17795-Conflict-of-interest statement.pdf
Copyright License Agreement	17795-Copyright assignment.pdf
Peer-review Report	17795-Peer-review(s).pdf
Scientific Misconduct Check	17795-Scientific misconduct check.pdf
Scientific Editor Work List	17795-Scientific editor work list.pdf